Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies

Since the first COVID-19 reports back in December of 2019, this viral infection caused by SARS-CoV-2 has claimed millions of lives. To control the COVID-19 pandemic, the Food and Drug Administration (FDA) and/or European Agency of Medicines (EMA) have granted Emergency Use Authorization (EUA) to nin...

Descripción completa

Detalles Bibliográficos
Autores principales: Almagro, Juan C., Mellado-Sánchez, Gabriela, Pedraza-Escalona, Martha, Pérez-Tapia, Sonia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456190/
https://www.ncbi.nlm.nih.gov/pubmed/36077159
http://dx.doi.org/10.3390/ijms23179763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456190/
https://www.ncbi.nlm.nih.gov/pubmed/36077159
http://dx.doi.org/10.3390/ijms23179763

Ejemplares similares